Search

Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD, has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital (MH) and holds the Edward P. Evans Endowed Chair for Myelodysplastic Syndromes at MSK.

… Thursday, October 16, 2025 Memorial Sloan Kettering Cancer Center (MSK) announced today that Ross Levine, MD , has been named MSK’s new Chief Scientific Officer (CSO). A renowned physician-scientist, Dr. Levine previously served as Senior Vice President of Translational Research in Memorial Hospital

In response to the intense fear that so many people experience around imaging tests, MSK radiology nurses developed new recommendations that are helping patients everywhere.

… Thursday, September 11, 2025 The cancer may be gone, but for many patients the medical tests continue, and so do the fear and worry.  Now, a group of radiology nurses at Memorial Sloan Kettering Cancer Center (MSK) say it’s time to bring awareness — and relief — to the countless patients and their caregivers

Learn how people with cancer can reduce insomnia during and after treatment.

… Thursday, March 15, 2018 Summary Many people with cancer suffer from insomnia, both during treatment and sometimes for years after. Effective insomnia treatments exist, including a special type of cognitive behavioral therapy. There are also relaxation techniques, acupuncture, and medication. Insomnia

A team of experts at Memorial Sloan Kettering shared their insights on colorectal cancer and general digestive health in an Information Session for patients, caregivers and those at increased risk for the disease.

… Thursday, June 25, 2020 A team of experts at Memorial Sloan Kettering shared their insights on colorectal cancer and general digestive health in an Information Session for patients, caregivers and those at increased risk for the disease.   Members of the MSK community joined the session to have their

Two new therapy options have demonstrated significant advances in survival outcomes for select patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Both studies were presented today at the 2025 ASCO Annual Meeting in Chicago and simultaneously published in The New England Journal of Medicine.

… Saturday, May 31, 2025 Two new therapy options have demonstrated significant advances in survival outcomes for select patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer. Both studies were presented today at the 2025 ASCO Annual

New MSK research identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife. MSK clinical trials also supported the recent approval of the targeted drug larotrectinib by the FDA.

… Wednesday, April 23, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) identifies a rare cell population responsible for AML persistence and resistance to therapy; sheds new light on early brain development; and investigates how other health conditions can increase cancer risk in midlife

Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research.

… Friday, May 1, 2009 Summary Charles L. Sawyers, Chair of the Human Oncology and Pathogenesis Program, has been awarded the 2009 Dorothy P. Landon Prize for Translational Cancer Research from the American Association for Cancer Research. Charles L. Sawyers , Chair of the Human Oncology and Pathogenesis

Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:

… Thursday, October 3, 2024 Memorial Sloan Kettering Cancer Center (MSK) today announced the following awards and appointments:   Yasmin Khakoo Received the 2024 American Medical Women’s Association INSPIRE Award and Elected to the Child Neurology Society Board of Directors Yasmin Khakoo, MD, FAAN, FACS

Learn why medical oncologist Ghassan Abou-Alfa counsels his patients with liver cancer to stop drinking.

… Wednesday, December 23, 2015 Summary Many people with primary liver cancer wonder if it’s safe to keep drinking alcohol. The fact is that alcohol is toxic to liver cells and consuming alcohol can accelerate liver damage with sometimes fatal consequences in people with this cancer. In addition, treatment

Inheriting a mutation in the CDH1 gene can raise risk of a rare stomach cancer called hereditary diffuse gastric cancer.

… Thursday, July 22, 2021 Stomach (gastric) cancer is the third leading cause of cancer deaths in the world today. About 10% of these cancers are due to a genetic mutation inherited from a parent. One specific mutation, called CDH1 , puts a person at very high risk for a rare but lethal form of stomach